RNA
Atrium Therapeutics, Inc.
8.30$
-1.7%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
Atrium Therapeutics, Inc. (RNA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -41 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -9.7 | 2.5 | -37 | -95 | -136 | -119 | -301 | -41 | |
| – | – | – | 0.4 | 0.3 | 0.4 | 0.6 | 1.4 | 2.1 | 2.8 | 0.3 | |
| – | – | – | 0.1 | 0.4 | 4.3 | 17 | 27 | 38 | 51 | 7.7 | |
| – | – | – | 0.4 | 7.4 | 4.5 | 17 | 27 | – | – | – | |
| – | – | – | 0.7 | 19 | 2.3 | 5.3 | 9.8 | 61 | -15 | -0.2 | |
| 2.6 | 0.3 | 0.8 | 0.0 | 0.2 | 1.1 | 3.7 | 2.8 | 4.2 | 7.1 | 1.4 | |
| – | – | – | 0.0 | -0.2 | -7.8 | -83 | -190 | -130 | -854 | -1.4 | |
| – | – | – | 0.1 | 0.1 | 0.4 | 0.0 | – | – | – | – | |
| – | – | – | 0.2 | 73 | 0.4 | – | – | – | – | – | |
| – | – | – | 5.0 | 17 | -4.7 | 0.0 | 0.0 | – | – | – | |
| 0.6 | 34 | 88 | 5.1 | 89 | 272 | 176 | 346 | 94 | 1,192 | 43 | |
| – | – | – | -4.6 | 91 | 227 | -1.0 | 20 | -155 | 37 | 163 | |
| – | – | – | -9.7 | 2.3 | -38 | -99 | -139 | -123 | -308 | -43 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.